Work

A phase 1 study of p53MVA vaccine in combination with pembrolizumab.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.5_suppl.206

Authors: Vincent M. Chung, Ferdynand Kos, Nicola Hardwick, Yuan Yuan, Joseph Chao, Mengsha Li, Kathryn Zurcher, Paul Henry Frankel, Daneng Li, James Ross Waisman, Don J. Diamond

Institution: City Of Hope National Medical Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2794307699

Cites:

Cited by: 15

Related to: 10